Drug
Difluprednate clinical trials
Also written Durezol.
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2002 (2)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2018 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 3
Sirion Therapeutics, Inc. (11) · Alcon Research (3) · Laboratorios Sophia S.A de C.V. (1) · Edward J. Holland (1) · University of California, San Francisco (1) · Kafrelsheikh University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Glucocorticoids source
Studies
Open first, then newest update. How each study uses difluprednate is read from its arms, and is right about nine times in ten.
Testing it · 18
- A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After PhacoemulsificationStatus unknownPhase 4Kafrelsheikh UniversityNCT05649111Written as Difluprednate Eye Drops
- Macular Edema Nepafenac vs. Difluprednate Uveitis TrialTerminatedPhase 4University of California, San FranciscoNCT01939691Written as Difluprednate
- Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After PhacoemulsificationCompletedPhase 3Laboratorios Sophia S.A de C.V.NCT03693989Written as Difluprednate 0.05%
- Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract SurgeryCompletedPhase 3Alcon ResearchNCT01124045Written as Difluprednate ophthalmic emulsion, 0.05%
- Evaluation of Anti-Inflammatory Treatment in Dry Eye PatientsCompletedPhase 2Alcon ResearchNCT01276223Written as Difluprednate 0.05% ophthalmic emulsion
- Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior UveitisCompletedPhase 3Alcon ResearchNCT01201798Written as Difluprednate 0.05% ophthalmic emulsion
- Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.CompletedPhase 4Edward J. HollandNCT01244334Written as Difluprednate ophthalmic emulsion 0.05%
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)CompletedPhase 3Sirion Therapeutics, Inc.NCT00616993Written as Difluprednate
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)CompletedPhase 3Sirion Therapeutics, Inc.NCT00616070Written as Difluprednate
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)CompletedPhase 3Sirion Therapeutics, Inc.NCT00430092Written as Difluprednate
- Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)CompletedPhase 3Sirion Therapeutics, Inc.NCT00429923Written as Difluprednate
- Study of Difluprednate in the Treatment of UveitisCompletedPhase 3Sirion Therapeutics, Inc.NCT00501579Written as Difluprednate
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative InflammationCompletedPhase 2Sirion Therapeutics, Inc.NCT00407225Written as Difluprednate Ophthalmic Emulsion
- Study of Difluprednate Ophthalmic Emulsion in Postoperative InflammationCompletedPhase 3Sirion Therapeutics, Inc.NCT00406341Written as Difluprednate Ophthalmic Emulsion
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe UveitisCompletedPhase 3Sirion Therapeutics, Inc.NCT00407056Written as Difluprednate Ophthalmic Emulsion
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative InflammationCompletedPhase 2Sirion Therapeutics, Inc.NCT00406497Written as Difluprednate Ophthalmic Emulsion
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of UveitisCompletedPhase 3Sirion Therapeutics, Inc.NCT00406887Written as Difluprednate Ophthalmic Emulsion
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of UveitisCompletedPhase 2Sirion Therapeutics, Inc.NCT00405496Written as Difluprednate Ophthalmic Emulsion
As the comparator · 1 — what is tested is compared with difluprednate
Codes
What other systems call difluprednate · ClinicalTrials.gg INT002635
- MeSH (NLM) C015808difluprednateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S8A06QG2QEDIFLUPREDNATEConfirmed FDA, NLM, Wikidata
- RxNorm 23043Confirmed FDA, Wikidata
- Wikidata Q736113difluprednateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C80259DifluprednateOne source FDA
- DrugBank DB06781One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C015808 | difluprednate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S8A06QG2QE | DIFLUPREDNATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 23043 | — | Confirmed FDA, Wikidata |
| Wikidata | Q736113 | difluprednate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C80259 | Difluprednate | One source FDA |
| DrugBank | DB06781 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.